Cargando…

A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus

BACKGROUND: The coexistence of cirrhosis complicates the early detection of hepatocellular carcinoma (HCC). Thus, novel biomarkers for HCC early detection are needed urgently. Traditionally, HCC detection is carried out by evaluating alpha-fetoprotein (AFP) levels combined with imaging techniques. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omran, Mohamed M., Mosaad, Sara, Emran, Tarek M., Eltaweel, Fathy M., Farid, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556404/ https://www.ncbi.nlm.nih.gov/pubmed/34714420 http://dx.doi.org/10.1186/s43141-021-00262-8

Ejemplares similares

Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
por: Omar, Mona A., et al.
Publicado: (2023)

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013)

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
por: Gabeen, Abdulwahab Ali, et al.
Publicado: (2014)

Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular Carcinoma
por: Metwaly, Heba A., et al.
Publicado: (2012)

Interleukin-6 increases the expression and activity of insulin-degrading enzyme
por: Kurauti, Mirian A., et al.
Publicado: (2017)

Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
por: Seo, J. H., et al.
Publicado: (1997)

Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer
por: Eldesoky, Ayman, et al.
Publicado: (2011)

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2014)

Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
por: Saber, Mohamed A, et al.
Publicado: (2017)

Influence of Interleukin-6 (174G/C) Gene Polymorphism on Obesity in Egyptian Children
por: Ibrahim, Ola M., et al.
Publicado: (2017)

Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression
por: Zhao, Li, et al.
Publicado: (2011)

Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats
por: Mukherjee, Biswajit, et al.
Publicado: (2005)

Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2021)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma
por: Mohamed, Amal A, et al.
Publicado: (2011)

Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance
por: Almuraikhy, Shamma, et al.
Publicado: (2016)

Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients
por: Sabry, Dina, et al.
Publicado: (2015)

IL-4, IL-17 and CD163 Immunoexpression and IL-6 Gene Polymorphism in Chronic Hepatitis C Patients and Associated Hepatocellular Carcinoma
por: Aboushousha, Tarek, et al.
Publicado: (2021)

Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4
por: Mabrouk, Nada M.K., et al.
Publicado: (2020)

Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
por: Garrett, Sara M., et al.
Publicado: (2019)

Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
por: Nenu, Iuliana, et al.
Publicado: (2023)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells
por: Chiron, D, et al.
Publicado: (2013)

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients
por: Elkammah, Maha, et al.
Publicado: (2021)

Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal Pregnancy
por: Jahromi, Abdolreza Sotoodeh, et al.
Publicado: (2014)

Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: Preliminary study
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2008)

Effect of Early Breast Milk Nutrition on Serum Insulin-Like Growth Factor-1 in Preterm Infants
por: Alzaree, Fatma A., et al.
Publicado: (2019)

Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor
por: Zavorka, Megan E., et al.
Publicado: (2016)

Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report
por: Abdel Wahab, Mohamed, et al.
Publicado: (2018)

Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients
por: Abdel-Tawab, Marwa S., et al.
Publicado: (2020)

AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1
por: Chen, Chong, et al.
Publicado: (2014)

Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
por: Zekry, Rania, et al.
Publicado: (2023)

Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling
por: Domfeh, Seth A., et al.
Publicado: (2021)

Targeting insulin-like growth factor axis in hepatocellular carcinoma
por: Wu, Jennifer, et al.
Publicado: (2011)

Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
por: Giudice, Jimena, et al.
Publicado: (2013)

Induction of synthesis of matrix metalloproteinases by interleukin-6; evidence for hepatic regeneration following hemi-hepatectomy
por: Alghamdi, Thamer, et al.
Publicado: (2020)

Interleukin-6 (IL-6) serum concentrations in dogs with hepatitis and hepatic tumours compared with those with extra-hepatic inflammation and tumours
por: Neumann, Stephan, et al.
Publicado: (2010)

Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle
por: Nieto-Vazquez, Iria, et al.
Publicado: (2008)

Salivary Interleukin-6 and C-Reactive Protein/Mean Platelet Volume Ratio in the Diagnosis of Late-Onset Neonatal Pneumonia
por: Omran, Ahmed, et al.
Publicado: (2021)

Tobacco Smoke-Induced Hepatic Injury with Steatosis, Inflammation, and Impairments in Insulin and Insulin-Like Growth Factor Signaling
por: de la Monte, Suzanne M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ah2vfh2qct6si1sgs744mu0hl